← 홈

ADC

1,068개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-13 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 1,068개
ADCBiologicstalePfizerPreclinical

Antibody Drug Conjugate Chemotherapeutic (Antibody Drug Conjugate Chemotherapeutic)

CD33 Positive Acute Myelogenous Leukemia · CD33

#CD33#ADC#Preclinical#항체약물접합체#antibody-drug-conjugate+2
효능 ORR 51%임상시험 8상태 ACTIVE
ADCBiologicstaleBayerPhase 1

BAY94-9343 (BAY94-9343)

Neoplasms · Oncology

#Oncology#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
효능 ORR 7.2%임상시험 8상태 ACTIVE
ADCBiologicstaleMedImmune LLCPhase 1

BL22 immunotoxin (BL22 immunotoxin)

Leukemia; Lymphoma · Leukemia

#Leukemia#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
효능 ORR 0%임상시험 8상태 ACTIVE
ADCBiologicstaleAbbViePhase 3

Depatuxizumab mafodotin (Depatuxizumab mafodotin)

Glioblastoma · Glioblastoma

#Glioblastoma#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+1
효능 ORR 14.3%임상시험 8상태 ACTIVE
ADCBiologicstaleGlaxoSmithKlinePhase 2

GSK5764227 (GSK5764227)

Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma · Recurrent/Metastatic Head and Neck Squam

#RecurrentMetastaticHeadandNeckSq#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
임상시험 8상태 RECRUITING
ADCBiologicstaleJanssen Research & Development,…Phase 1

JNJ-78278343 (JNJ-78278343)

Prostatic Neoplasms · Prostatic Neoplasms

#ProstaticNeoplasms#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
임상시험 8상태 RECRUITING
ADCBiologicstaleMiltenyi Biomedicine GmbHPhase 2

MB-CART2019.1 (MB-CART2019.1)

Diffuse Large B-cell Lymphoma · Diffuse Large B-cell Lymphoma

#DiffuseLargeB-cellLymphoma#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 8상태 RECRUITING
ADCBiologicstaleGlaxoSmithKlinePhase 2

PI3K-beta Inhibitor GSK2636771 (PI3K-beta Inhibitor GSK2636771)

Advanced Lymphoma; Advanced Malignant Solid Neoplasm · FRα

#FR#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
효능 ORR 9%임상시험 8상태 RECRUITING
ADCBiologicGenmabPhase 3

Rina-S (Rina-S)

High Grade Epithelial Ovarian Cancer; High Grade Serous Ovarian Cancer · Platinum-resistant Ovarian Cancer

#Platinum-resistantOvarianCancer#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+3
임상시험 8상태 RECRUITING
ADCBiologicstaleGenmabApproved

TIVDAK (TIVDAK)

Cervical Cancer · Cervical Cancer

#CervicalCancer#ADC#Approved#항체약물접합체#antibody-drug-conjugate+1
효능 ORR 23.8%임상시험 8상태 RECRUITING
ADCBiologicstaleDaiichi SankyoPhase 1

Valemetostat tosylate (Valemetostat tosylate)

Advanced Solid Tumor · Advanced Solid Tumor

#AdvancedSolidTumor#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
효능 ORR 43.7%임상시험 8상태 RECRUITING
ADCBiologicstaleRegeneron PharmaceuticalsPhase 2

vidutolimod (vidutolimod)

Merkel Cell Carcinoma; Cutaneous Squamous Cell Carcinoma · Merkel Cell Carcinoma

#MerkelCellCarcinoma#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
효능 ORR 56%임상시험 8상태 DISCONTINUED
ADCBiologicstaleHoffmann-La RochePhase 2

Camonsertib (Camonsertib)

Solid Tumors · Solid Tumors

#SolidTumors#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
효능 ORR 33.3%임상시험 7상태 RECRUITING
ADCBiologicstaleCanadian Myeloma Research GroupPhase 2

GSK2857916 with Pomalidomide and Dexamethasone (GSK2857916 with Pomalidomide and Dexamethasone)

Relapsed and/or Refractory Multiple Myeloma · FRα

#FR#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
효능 ORR 100%임상시험 7상태 RECRUITING
ADCBiologicstaleShanghai Henlius BiotechPhase 2

HLX22 (HLX22)

HER2-low Hormone Receptor Positive Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 7상태 RECRUITING
ADCBiologicShanghai Junshi Bioscience Co.,…Phase 2

JS212 (JS212)

Non-squamous Non-small Cell Lung Cancer · Metastatic Colorectal Cancer

#MetastaticColorectalCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 7상태 RECRUITING
ADCBiologicstaleSuzhou Maximum Bio-tech Co., Lt…Phase 2

MT027 (MT027)

Rare Malignant Neoplasm; Advanced Solid Tumors · Rare Malignant Neoplasm

#RareMalignantNeoplasm#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 7상태 RECRUITING
ADCBiologicstaleConvalife (Shanghai) Co., Ltd.Phase 1

Neratinib Maleate (Neratinib Maleate)

Metastatic Malignant Solid Neoplasm; Unresectable Malignant Solid Neoplasm · Metastatic Malignant Solid Neoplasm

#MetastaticMalignantSolidNeoplasm#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 7상태 DISCONTINUED
ADCBiologicstaleRemeGen Co., Ltd.Phase 3

disitamab vedotin (Disitamab Vedotin, RC48, RC48-ADC（2.5mg/kg）)

Gastric Cancer · Gastric Cancer

#GastricCancer#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+1
임상시험 7상태 RECRUITING
ADCBiologicstaleMerck Sharp & Dohme LLCPhase 2

Raludotatug deruxtecan (Raludotatug deruxtecan)

Ovarian Cancer Recurrent · Advanced Solid Tumor

#AdvancedSolidTumor#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 7상태 RECRUITING

25 / 54 페이지

← 이전다음 →